DNA co-methylation analysis of lincRNAs across nine cancer types reveals novel potential epigenetic biomarkers in cancer
Lists
Only you see this
Abstract
<b>Aim:</b> The potential functions and prognostic value of lincRNAs with co-methylation events are explored in 9 cancer types. <b>Materials & methods:</b> Here, we evaluated the co-methylation events in promoter and gene-body regions between two lincRNAs across 9 cancer types by constructing a systematic biological framework. <b>Results:</b> The co-methylation events in both promoter and gene-body regions tended to be highly cancer specific. Patient samples could be separated by tumor and normal types according to the eigengenes of universal co-methylation clusters. Functional enrichment results revealed the lincRNAs that brought promoter and gene-body co-methylation events that affected cancer progress through participating in different pathways and could serve as potential prognostic biomarkers. <b>Conclusion:</b> The study provides new insight into the epigenetic regulation in cancer and leads to a potential new direction for epigenetic biomarker discovery.
BibTeX
@inproceedings{wei2019dna,
author = {Yunzhen Wei and Siyao Dong and Yanjiao Zhu and Yichuan Zhao and Cheng Wu and Yinling Zhu and Kun Li and Yan Xu},
title = {{DNA co-methylation analysis of lincRNAs across nine cancer types reveals novel potential epigenetic biomarkers in cancer}},
booktitle = {Epigenomics},
year = {2019},
doi = {10.2217/epi-2018-0138},
}Loading related content...